- Home
- QGEN vs TFX Comparison
QGEN vs TFX Comparison
Compare QGEN & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QGEN
- TFX
- Stock Information
- Founded
- QGEN 1986
- TFX 1943
- Country
- QGEN Netherlands
- TFX United States
- Employees
- QGEN N/A
- TFX N/A
- Industry
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- TFX Medical/Dental Instruments
- Sector
- QGEN Health Care
- TFX Health Care
- Exchange
- QGEN Nasdaq
- TFX Nasdaq
- Market Cap
- QGEN 9.7B
- TFX 9.0B
- IPO Year
- QGEN 1996
- TFX N/A
- Fundamental
- Price
- QGEN $42.14
- TFX $190.54
- Analyst Decision
- QGEN Buy
- TFX Buy
- Analyst Count
- QGEN 9
- TFX 9
- Target Price
- QGEN $51.05
- TFX $259.00
- AVG Volume (30 Days)
- QGEN 917.8K
- TFX 531.9K
- Earning Date
- QGEN 11-06-2024
- TFX 10-31-2024
- Dividend Yield
- QGEN 3.17%
- TFX 0.73%
- EPS Growth
- QGEN N/A
- TFX N/A
- EPS
- QGEN 0.41
- TFX 5.03
- Revenue
- QGEN $1,966,174,000.00
- TFX $3,025,824,000.00
- Revenue This Year
- QGEN $2.68
- TFX $4.52
- Revenue Next Year
- QGEN $5.95
- TFX $4.92
- P/E Ratio
- QGEN $98.41
- TFX $37.26
- Revenue Growth
- QGEN 0.62
- TFX 2.27
- 52 Week Low
- QGEN $39.03
- TFX $185.84
- 52 Week High
- QGEN $47.44
- TFX $257.85
- Technical
- Relative Strength Index (RSI)
- QGEN 45.99
- TFX 26.26
- Support Level
- QGEN $40.35
- TFX $185.66
- Resistance Level
- QGEN $42.42
- TFX $195.47
- Average True Range (ATR)
- QGEN 0.81
- TFX 4.86
- MACD
- QGEN -0.09
- TFX -0.49
- Stochastic Oscillator
- QGEN 37.40
- TFX 9.13
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.